Cargando…

Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews

OBJECTIVE: To synthesise evidence from exclusively primary prevention data on the effectiveness of statins for prevention of cardiovascular disease (CVD), including stroke, and outcomes stratified by baseline risk and gender. DESIGN: Overview of systematic reviews (SRs) using Revised-AMSTAR approach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byrne, Paula, Cullinan, John, Smith, Amelia, Smith, Susan M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500096/ https://www.ncbi.nlm.nih.gov/pubmed/31015265 http://dx.doi.org/10.1136/bmjopen-2018-023085

Ejemplares similares

Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease
por: Byrne, Paula, et al.
Publicado: (2018)

Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
por: Studzin´ski, Krzysztof, et al.
Publicado: (2017)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Commentary: Beyond 10-year risk: A cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
por: Shah, Aditya, et al.
Publicado: (2022)

Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials
por: Zhou, Zhen, et al.
Publicado: (2017)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England
por: O'Keeffe, Aidan G, et al.
Publicado: (2015)

Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis
por: Wang, Ying, et al.
Publicado: (2018)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023)

Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Lai, Runmin, et al.
Publicado: (2020)

Primary and secondary cardiovascular disease prevention interventions targeting lifestyle risk factors in women: A systematic review and meta-analysis
por: Slater, Kaylee, et al.
Publicado: (2022)

Health literacy and cardiovascular disease prevention: a systematic scoping review protocol
por: Beasant, Bonnie, et al.
Publicado: (2022)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
por: Chen, Yinong, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Beltrán Romero, Luis M., et al.
Publicado: (2021)

Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
por: He, Nana, et al.
Publicado: (2021)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials
por: Wang, Xinyi, et al.
Publicado: (2022)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review
por: Usher-Smith, Juliet A, et al.
Publicado: (2015)

Legacy effects of statins on cardiovascular and all-cause mortality: a meta-analysis
por: Nayak, Agnish, et al.
Publicado: (2018)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

What are the gaps in cardiovascular risk assessment and management in primary care for Māori and Pacific people in Aotearoa New Zealand? Protocol for a systematic review
por: Brewer, Karen Marie, et al.
Publicado: (2022)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
por: Tudor, Kate, et al.
Publicado: (2020)

Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease
por: Hope, Holly F., et al.
Publicado: (2019)

Interventions for the prevention of cardiovascular diseases: a protocol for a systematic review of economic evaluations in low-income and middle-income countries
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2016)

Text messages for primary prevention of cardiovascular disease: the TextMe2 randomised controlled trial protocol
por: Klimis, Harry, et al.
Publicado: (2020)

Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews
por: Al-Gobari, Muaamar, et al.
Publicado: (2018)

Hydrophilic or Lipophilic Statins?
por: Climent, Elisenda, et al.
Publicado: (2021)

Comparative efficacy and acceptability of different antihypertensive drug classes for cardiovascular disease prevention: protocol for a systematic review and network meta-analysis
por: Jussil, Heidi, et al.
Publicado: (2021)

Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
por: Davis, John W, et al.
Publicado: (2021)

Protocol for the evaluation of a pilot implementation of essential interventions for the prevention of cardiovascular diseases in primary healthcare in the Republic of Moldova
por: Collins, Dylan, et al.
Publicado: (2019)

High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
por: Leite, Luis, et al.
Publicado: (2022)

Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
por: Toth, Peter P., et al.
Publicado: (2023)

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions
por: Fitch, Kathleen V., et al.
Publicado: (2022)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
por: Volterrani, Maurizio, et al.
Publicado: (2023)

Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
por: Ogawa, Kazuo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bujlgg0ls66b8theknt3uabos2